Spruce Biosciences Statistics
Total Valuation
SPRBD has a market cap or net worth of 3.94 million. The enterprise value is -10.62 million.
Market Cap | 3.94M |
Enterprise Value | -10.62M |
Important Dates
The last earnings date was Friday, August 8, 2025.
Earnings Date | Aug 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SPRBD has 563,042 shares outstanding. The number of shares has increased by 4.46% in one year.
Current Share Class | 563,042 |
Shares Outstanding | 563,042 |
Shares Change (YoY) | +4.46% |
Shares Change (QoQ) | +0.89% |
Owned by Insiders (%) | 6.58% |
Owned by Institutions (%) | 9.01% |
Float | 457,375 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3.03 |
PB Ratio | 0.30 |
P/TBV Ratio | 0.30 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 0.22 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.60, with a Debt / Equity ratio of 0.14.
Current Ratio | 2.60 |
Quick Ratio | 2.03 |
Debt / Equity | 0.14 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -263.89 |
Financial Efficiency
Return on equity (ROE) is -133.62% and return on invested capital (ROIC) is -81.34%.
Return on Equity (ROE) | -133.62% |
Return on Assets (ROA) | -65.06% |
Return on Invested Capital (ROIC) | -81.34% |
Return on Capital Employed (ROCE) | -368.21% |
Revenue Per Employee | 144,333 |
Profits Per Employee | -5.37M |
Employee Count | 21 |
Asset Turnover | 0.03 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.10% in the last 52 weeks. The beta is 2.44, so SPRBD's price volatility has been higher than the market average.
Beta (5Y) | 2.44 |
52-Week Price Change | -80.10% |
50-Day Moving Average | 7.65 |
200-Day Moving Average | 18.86 |
Relative Strength Index (RSI) | 37.33 |
Average Volume (20 Days) | 2,572 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.07 |
Income Statement
In the last 12 months, SPRBD had revenue of 1.30 million and -48.34 million in losses. Loss per share was -84.75.
Revenue | 1.30M |
Gross Profit | -38.68M |
Operating Income | -50.67M |
Pretax Income | -48.34M |
Net Income | -48.34M |
EBITDA | -50.63M |
EBIT | -50.67M |
Loss Per Share | -84.75 |
Balance Sheet
The company has 16.39 million in cash and 1.82 million in debt, giving a net cash position of 14.56 million or 25.87 per share.
Cash & Cash Equivalents | 16.39M |
Total Debt | 1.82M |
Net Cash | 14.56M |
Net Cash Per Share | 25.87 |
Equity (Book Value) | 13.18M |
Book Value Per Share | 23.41 |
Working Capital | 12.89M |
Cash Flow
Operating Cash Flow | -51.46M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | -3,900.38% |
Pretax Margin | -3,721.17% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
SPRBD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -4.46% |
Shareholder Yield | n/a |
Earnings Yield | -1,226.45% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on August 7, 2025. It was a reverse split with a ratio of 0.0133333.
Last Split Date | Aug 7, 2025 |
Split Type | Reverse |
Split Ratio | 0.0133333 |
Scores
SPRBD has an Altman Z-Score of -22.93. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -22.93 |
Piotroski F-Score | n/a |